SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported third-quarter earnings of $53.8 million.
The San Diego-based company said it had net income of 56 cents per share. Earnings, adjusted for non-recurring costs, were 79 cents per share.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 66 cents per share.
The biopharmaceutical company posted revenue of $222.1 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $211.2 million.
Neurocrine shares have climbed 43% since the beginning of the year. In the final minutes of trading on Monday, shares hit $102.42, a drop of 12% in the last 12 months.